Long-term administration of berberine increases the expression of IL-1β and inducible nitric oxide synthase (iNOS) in Alzheimer’s disease mice hippocampus, and ameliorate memory impairment (Zhu and Qian, 2006). The gene discussed is IL1B; the disease is early-onset autosomal dominant Alzheimer disease.